-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Bionik Laboratories Corp. annual/quarterly Net Cash Provided by (Used in) Investing Activities history and growth rate from Q2 2017 to Q2 2022.
- Bionik Laboratories Corp. Net Cash Provided by (Used in) Investing Activities for the quarter ending June 30, 2022 was $0.000.
- Bionik Laboratories Corp. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$224K, a 1690% decline from 2021.
- Bionik Laboratories Corp. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$12.5K.
- Bionik Laboratories Corp. annual Net Cash Provided by (Used in) Investing Activities for 2020 was $0.000.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)